Focus:
Analysis
-
![Road to RECOVERY: A deep dive into the world’s largest Covid-19 drug trial]()
Road to RECOVERY: A deep dive into the world’s largest Covid-19 drug trial
The University of Oxford-led RECOVERY trial is the world’s largest clinical trial, with more than 10,000 patients recruited across the UK. The wide-ranging trial aims to assess the anti-Covid-19 efficacy...
-
![Charting the ups and downs of the World Health Organization]()
Charting the ups and downs of the World Health Organization
Central to the world’s response to this deadly novel coronavirus has been the UN’s WHO, which has, for better or worse, provided leadership to governments grappling with local epidemics. Allie Nawrat reflects...
-
![AstraZeneca and Veeva: reducing disruption from the Covid-19 pandemic]()
AstraZeneca and Veeva: reducing disruption from the Covid-19 pandemic
The Covid-19 pandemic has challenged all industries, and pharma is no exception, with some clinical trials struggling to continue as normal. To this end, pharma companies like AstraZeneca, and the...
-
![C4T raises $170m for human trials of degrader drugs]()
C4T raises $170m for human trials of degrader drugs
C4T has raised $170m from a Series B round and venture debt funding. This influx of capital will be used to move its four lead degrader drugs into clinical trials...
-
![Pharma Technology Focus: Breaking the BBB]()
Pharma Technology Focus: Breaking the BBB
Pharma Technology Focus is now available on all devices. Read it for free here The World Health Organization has come under fire for its handling of the Covid-19 pandemic, with critics...
-
![Novo Nordisk moves further into CV diseases with Corvidia acquisition]()
Novo Nordisk moves further into CV diseases with Corvidia acquisition
Cardio-renal specialist Corvidia Therapeutics has been acquired for $725m by diabetes giant Novo Nordisk. This deal builds on Novo Nordisk’s recent move into the CV space through outcomes trials of...
-
![Could nanoparticles unlock the benefits of turmeric?]()
Could nanoparticles unlock the benefits of turmeric?
The failure of the body to easily absorb curcumin has thwarted trials to discover usable pharmaceutical properties, until now. Researchers from the University of South Australia, McMaster University in Canada...
-
![Twitter round-up: Atul Gupta’s tweet on anticoagulants improving survival of Covid-19 patients most popular tweet in May 2020]()
Twitter round-up: Atul Gupta’s tweet on anticoagulants improving survival of Covid-19 patients most popular tweet in May 2020
Anticoagulants lead as Pharmaceutical Technology lists ten of the most popular tweets on cardiovascular in May 2020, based on data from GlobalData’s Influencer Platform. The top tweets were chosen from...
-
![Digital Biomarkers: Healthcare Trends]()
Digital Biomarkers: Healthcare Trends
The increase in use and popularity of connected digital devices and health-related mobile apps has produced a novel set of large, diverse, and complex data sets known as “digital biomarkers.”...
-
![Calliditas IPO raises $90m to support rare disease pipeline]()
Calliditas IPO raises $90m to support rare disease pipeline
Calliditas has raised $90m in its IPO to support the development and commercialisation of its lead candidate Nefecon in IgAN, a rare kidney disease. What other rare diseases are Calliditas...
